Clozapine Discontinuation and Malignant Catatonia: A Case Report

Psychosomatics. 2019 Jan-Feb;60(1):75-79. doi: 10.1016/j.psym.2018.03.007. Epub 2018 Mar 21.

Authors

Leonid Kapulsky¹, Miranda G Greiner², Jessica E Daniels², Janna S Gordon-Elliott²

Affiliations

¹ NewYork-Presbyterian Hospital (L.K., M.G.G., J.E.D., J.S.G.E.), Weill Cornell Medical Center, New York, NY. Electronic address: lek9035@nyp.org.
² NewYork-Presbyterian Hospital (L.K., M.G.G., J.E.D., J.S.G.E.), Weill Cornell Medical Center, New York, NY.

PMID: 29703551
DOI: 10.1016/j.psym.2018.03.007

No abstract available

Publication types

Case Reports

MeSH terms

Antipsychotic Agents / adverse effects*
Antipsychotic Agents / therapeutic use
Benztropine / therapeutic use
Catatonia / chemically induced*
Catatonia / drug therapy
Clozapine / adverse effects*
Clozapine / therapeutic use
Humans
Male
Muscarinic Antagonists / therapeutic use
Schizophrenia / drug therapy*
Substance Withdrawal Syndrome / drug therapy
Substance Withdrawal Syndrome / etiology*
Young Adult

Substances

Antipsychotic Agents
Muscarinic Antagonists
Benztropine
Clozapine